Replies to post #209962 on Biotech Values

[semi_infinite]

Two scenarios. Flat revenues, half of your best case growth guess.

[semi_infinite]

thx. I still own the shares I bought on the dip into low 20's from last year. Have also traded out of some in IRAs via option assignment. HCV gets a low npv and nobody knows how GILD will respond to g/p competition so there are uncertainties in market share and pricing.